Loading...

URGN UROGEN PHARMA LTD Earnings Reports 8-K Filing

RGN

RGN

UROGEN PHARMA LTD

(URGN)

2025 8-K

Patent Settlement

Financial Results Announcement

Financial Results Report

Loan Agreement Details

Financial Results Report

Shareholder Approvals

Financial Statements

Compensatory Arrangements o...

New Product Launches

Financial Statements

Financial Results

Asset Acquisition

Investor Presentation

Financial Results

Director Resignation

Financial Results

Annual Meeting Approval

Public Offering

Positive Data from Phase 3 ...

Financial Results Announcement

Financial Results Announcement

Presentation at Conference

Notice of ANDA Submission

Agreement and Phase 3 Study

Amendment to Manufacturing ...

Financial Results Announcement

Annual Meeting of Shareholders

Financial Results Announcement

Private Placement

Financial Results Announcement

External Links:

On August 7, 2025, UroGen Pharma Ltd. reported its financial results for the second quarter ending June 30, 2025, providing key insights into its operations. This filing is significant for investors as it includes important performance metrics.

AI Assistant

UROGEN PHARMA LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.